While in vitro and animal studies have suggested that NTX may restore the functionality of the OGF-OGFr axis and suppress tumor growth [25,29,30], the mechanistic OGF-OGFr effect has not been consistently replicated across the literature and findings remain controversial regarding dosing, treatment schedule, and mechanism of action [21]. The gene discussed is OGFR; the disease is neoplasm.